rs373406834

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_004484.4(GPC3):​c.672A>G​(p.Gln224Gln) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000091 in 1,209,418 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000045 ( 0 hom., 3 hem., cov: 23)
Exomes 𝑓: 0.0000055 ( 0 hom. 1 hem. )

Consequence

GPC3
NM_004484.4 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: 0.822

Publications

0 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-133753842-T-C is Benign according to our data. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663. Variant chrX-133753842-T-C is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476663.
BP7
Synonymous conserved (PhyloP=0.822 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0000447 (5/111953) while in subpopulation AFR AF = 0.000163 (5/30754). AF 95% confidence interval is 0.0000637. There are 0 homozygotes in GnomAd4. There are 3 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 3 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GPC3NM_004484.4 linkc.672A>G p.Gln224Gln synonymous_variant Exon 3 of 8 ENST00000370818.8 NP_004475.1 P51654-1Q53H15I6QTG3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GPC3ENST00000370818.8 linkc.672A>G p.Gln224Gln synonymous_variant Exon 3 of 8 1 NM_004484.4 ENSP00000359854.3 P51654-1

Frequencies

GnomAD3 genomes
AF:
0.0000447
AC:
5
AN:
111953
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.000163
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000220
AC:
4
AN:
182073
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000228
Gnomad AMR exome
AF:
0.0000365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000547
AC:
6
AN:
1097465
Hom.:
0
Cov.:
33
AF XY:
0.00000276
AC XY:
1
AN XY:
362831
show subpopulations
African (AFR)
AF:
0.0000758
AC:
2
AN:
26388
American (AMR)
AF:
0.0000568
AC:
2
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19377
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30204
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54133
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4135
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841418
Other (OTH)
AF:
0.0000217
AC:
1
AN:
46069
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000447
AC:
5
AN:
111953
Hom.:
0
Cov.:
23
AF XY:
0.0000880
AC XY:
3
AN XY:
34107
show subpopulations
African (AFR)
AF:
0.000163
AC:
5
AN:
30754
American (AMR)
AF:
0.00
AC:
0
AN:
10571
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2653
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3555
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2659
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6121
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
237
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
53206
Other (OTH)
AF:
0.00
AC:
0
AN:
1512
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000982

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary cancer-predisposing syndrome Uncertain:1
Feb 10, 2022
Sema4, Sema4
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Wilms tumor 1 Benign:1
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
6.4
DANN
Benign
0.58
PhyloP100
0.82
PromoterAI
0.0080
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs373406834; hg19: chrX-132887869; API